141 related articles for article (PubMed ID: 20192074)
1. [Long-term response of liver metastases of breast cancer to capecitabine--case report].
Macková D
Klin Onkol; 2010; 23(1):46-8. PubMed ID: 20192074
[TBL] [Abstract][Full Text] [Related]
2. Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.
Glück S; Castrellon A
Am J Ther; 2009; 16(6):585-90. PubMed ID: 19287304
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report.
Tham YL; Hinckley L; Teh BS; Elledge R
Clin Breast Cancer; 2006 Jun; 7(2):164-6. PubMed ID: 16800978
[TBL] [Abstract][Full Text] [Related]
4. [A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy].
Sato T; Nakagawa T; Kuwayama T; Oda G; Sugimoto H; Ishiba T; Sugihara K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2180-2. PubMed ID: 22202322
[TBL] [Abstract][Full Text] [Related]
5. [A case of metastatic breast cancer with bilateral hydronephrosis effectively treated with capecitabine].
Yamauchi S; Nakagawa T; Kasahara M; Sugimoto H; Ishiba T; Tamura N; Nagahara M; Sato T; Sugihara K
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2077-9. PubMed ID: 23267982
[TBL] [Abstract][Full Text] [Related]
6. [Successful treatment of trastuzumab-resistant HER2-positive breast cancer with extensive liver metastases using the combination of trastuzumab and capecitabine - a case report].
Shigekawa T; Takeuchi H; Misumi M; Nakamiya N; Sugiyama M; Sugitani I; Fujiuchi N; Osaki A; Saeki T
Gan To Kagaku Ryoho; 2013 Feb; 40(2):225-7. PubMed ID: 23411960
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
Gajria D; Gonzalez J; Feigin K; Patil S; Chen C; Theodoulou M; Drullinsky P; D'Andrea G; Lake D; Norton L; Hudis CA; Traina TA
Breast Cancer Res Treat; 2012 Jan; 131(1):111-6. PubMed ID: 21898114
[TBL] [Abstract][Full Text] [Related]
8. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
Ghosal N; Misra V
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
[No Abstract] [Full Text] [Related]
9. Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.
Saadati H; Saif MW
JOP; 2008 May; 9(3):354-6. PubMed ID: 18469454
[No Abstract] [Full Text] [Related]
10. [A case of local-recurring breast cancer under long term-treatment by capecitabine].
Yoneyama K; Takeshita T; Suzuki H; Morise M; Suzuki T; Kishi S; Tsutsui A; Matsumoto A
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2623-5. PubMed ID: 22189229
[TBL] [Abstract][Full Text] [Related]
11. [A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide].
Iida S; Furukawa K; Yokoyama T; Yanagihara K; Iwasaki R; Noguchi T; Tsuchiya S; Sugisaki Y; Naito Z; Tajiri T
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1697-700. PubMed ID: 17940394
[TBL] [Abstract][Full Text] [Related]
12. Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse.
Hikino H; Yamada T; Johbara K; Obayashi N; Ozaki N
Breast; 2006 Feb; 15(1):97-9. PubMed ID: 16005228
[TBL] [Abstract][Full Text] [Related]
13. Complete response of brain metastases originating in breast cancer to capecitabine therapy.
Siegelmann-Danieli N; Stein M; Bar-Ziv J
Isr Med Assoc J; 2003 Nov; 5(11):833-4. PubMed ID: 14650117
[No Abstract] [Full Text] [Related]
14. Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer.
Osako T; Ito Y; Ushijima M; Takahashi S; Tokudome N; Sugihara T; Iwase T; Matsuura M; Hatake K
Cancer Chemother Pharmacol; 2009 Apr; 63(5):865-71. PubMed ID: 18670777
[TBL] [Abstract][Full Text] [Related]
15. Capecitabine monotherapy is efficient and safe in all line settings in patients with metastatic and advanced breast cancer.
Amari M; Ishida T; Takeda M; Ohuchi N
Jpn J Clin Oncol; 2010 Mar; 40(3):188-93. PubMed ID: 19887522
[TBL] [Abstract][Full Text] [Related]
16. Actinic keratosis and capecitabine therapy.
Higa GM; Kovach RF; Abraham J
J Oncol Pharm Pract; 2005 Dec; 11(4):151-3. PubMed ID: 16595067
[TBL] [Abstract][Full Text] [Related]
17. [Case report of advanced breast cancer responding to capecitabine and trastuzumab combination therapy].
Yoshidome K; Imabun S; Nakahara M; Hiraoka K; Yamagami Y; Tsujimoto M; Nakao K
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1453-6. PubMed ID: 17033236
[TBL] [Abstract][Full Text] [Related]
18. [A case of recurrent breast cancer successfully treated with capecitabine monotherapy].
Mitsuyama S; Anan K; Ono M
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1153-7. PubMed ID: 16121919
[TBL] [Abstract][Full Text] [Related]
19. Ulcerated plaques in the pelvic region of an adult female.
Barrick B; Matthys B; Fraga G
Dermatol Online J; 2012 Oct; 18(10):7. PubMed ID: 23122014
[TBL] [Abstract][Full Text] [Related]
20. Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow?
Fabi A; Vidiri A; Ferretti G; Felici A; Papaldo P; Carlini P; Mirri A; Nuzzo C; Cognetti F
Cancer Invest; 2006; 24(4):466-8. PubMed ID: 16777702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
